(Q40968909)

English

The economic effects of introducing vigabatrin, a new antiepileptic medication

scientific article published on November 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

The economic effects of introducing vigabatrin, a new antiepileptic medication (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

author name string

D Reinharz

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

W Kennedy

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

A P Contandriopoulos

3

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

G Tessier

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

F Champagne

5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

publication date

1 November 1995

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

400-409

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

https://scigraph.springernature.com/pub.10.2165/00019053-199508050-00004

0 references

A multicentre study of vigabatrin for drug-resistant epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin in childhood epilepsy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of vigabatrin for the GABAergic system in human epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modern treatment strategies for patients with epilepsy: a review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin in pediatric epilepsy--an open study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10160074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199508050-00004

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40968909&oldid=1911296205"